BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chey WD, Keefer L, Whelan K, Gibson PR. Behavioral and Diet Therapies in Integrated Care for Patients With Irritable Bowel Syndrome. Gastroenterology 2021;160:47-62. [PMID: 33091411 DOI: 10.1053/j.gastro.2020.06.099] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 28.0] [Reference Citation Analysis]
Number Citing Articles
1 Jacobs JP, Lagishetty V, Hauer MC, Labus JS, Dong TS, Toma R, Vuyisich M, Naliboff BD, Lackner JM, Gupta A, Tillisch K, Mayer EA. Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes. Microbiome 2023;11:5. [PMID: 36624530 DOI: 10.1186/s40168-022-01450-5] [Reference Citation Analysis]
2 Atkins M, Zar-Kessler C, Madva EN, Staller K, Eddy KT, Thomas JJ, Kuo B, Burton Murray H. History of trying exclusion diets and association with avoidant/restrictive food intake disorder in neurogastroenterology patients: A retrospective chart review. Neurogastroenterol Motil 2023;:e14513. [PMID: 36600490 DOI: 10.1111/nmo.14513] [Reference Citation Analysis]
3 Rej A, Sanders DS, Shaw CC, Buckle R, Trott N, Agrawal A, Aziz I. Efficacy and Acceptability of Dietary Therapies in Non-Constipated Irritable Bowel Syndrome: A Randomized Trial of Traditional Dietary Advice, the Low FODMAP Diet, and the Gluten-Free Diet. Clin Gastroenterol Hepatol 2022;20:2876-2887.e15. [PMID: 35240330 DOI: 10.1016/j.cgh.2022.02.045] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
4 Kinsinger SW. Practical Approaches to Working with a Gastrointestinal Psychologist. Gastroenterol Clin North Am 2022;51:711-21. [PMID: 36375991 DOI: 10.1016/j.gtc.2022.07.002] [Reference Citation Analysis]
5 Burton Murray H, Ljótsson B. Future of Brain-Gut Behavior Therapies: Mediators and Moderators. Gastroenterol Clin North Am 2022;51:723-39. [PMID: 36375992 DOI: 10.1016/j.gtc.2022.06.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ruddy J, Taft T. The Pervasive Impact of the Stigmatization of Gastrointestinal Diseases-A Patient's Perspective. Gastroenterol Clin North Am 2022;51:681-95. [PMID: 36375989 DOI: 10.1016/j.gtc.2022.06.010] [Reference Citation Analysis]
7 Aycan M, Açikgöz Pinar A. Lactose Intolerance and Osteoporosis Development in Irritable Bowel Syndrome Patients. Bandırma Onyedi Eylül Üniversitesi Sağlık Bilimleri ve Araştırmaları Dergisi 2022. [DOI: 10.46413/boneyusbad.1184664] [Reference Citation Analysis]
8 Fitzpatrick JA, Melton SL, Yao CK, Gibson PR, Halmos EP. Dietary management of adults with IBD - the emerging role of dietary therapy. Nat Rev Gastroenterol Hepatol 2022;19:652-69. [PMID: 35577903 DOI: 10.1038/s41575-022-00619-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
9 Nordin E, Hellström PM, Brunius C, Landberg R. Modest Conformity Between Self-Reporting of Bristol Stool Form and Fecal Consistency Measured by Stool Water Content in Irritable Bowel Syndrome and a FODMAP and Gluten Trial. Am J Gastroenterol 2022;117:1668-74. [PMID: 36087104 DOI: 10.14309/ajg.0000000000001942] [Reference Citation Analysis]
10 Gibson PR, Halmos EP. The FODMAP diet: more than just a symptomatic therapy? Gut 2022;71:1693-4. [PMID: 34810233 DOI: 10.1136/gutjnl-2021-326284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Abdelghafar YA, Abdelqadir YH, Motawea KR, Nasr SA, Omran HAM, Belal MM, Elhashash MM, Abdelazim AA, Shah J. Efficacy and safety of fecal microbiota transplant in irritable bowel syndrome: An update based on meta‐analysis of randomized control trials. Health Science Reports 2022;5. [DOI: 10.1002/hsr2.814] [Reference Citation Analysis]
12 Thwaites PA, Gibson PR, Burgell RE. Hypermobile Ehlers-Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know. J Gastroenterol Hepatol 2022;37:1693-709. [PMID: 35750466 DOI: 10.1111/jgh.15927] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Chen Y, Lian B, Li P, Yao S, Hou Z. Studies on irritable bowel syndrome associated with anxiety or depression in the last 20 years: A bibliometric analysis. Front Public Health 2022;10:947097. [PMID: 36045729 DOI: 10.3389/fpubh.2022.947097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Biesiekierski JR, Manning LP, Murray HB, Vlaeyen JWS, Ljótsson B, Van Oudenhove L. Review article: exclude or expose? The paradox of conceptually opposite treatments for irritable bowel syndrome. Aliment Pharmacol Ther 2022;56:592-605. [PMID: 35775328 DOI: 10.1111/apt.17111] [Reference Citation Analysis]
15 Tuck CJ, Sultan N, Tonkovic M, Biesiekierski JR. Orthorexia nervosa is a concern in gastroenterology: A scoping review. Neurogastroenterol Motil 2022;34:e14427. [PMID: 35811419 DOI: 10.1111/nmo.14427] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Lu Q, Tan D, Luo J, Ye Y, Zuo M, Wang S, Li C. Potential of natural products in the treatment of irritable bowel syndrome. Phytomedicine 2022. [DOI: 10.1016/j.phymed.2022.154419] [Reference Citation Analysis]
17 Quigley EMM. Gastrointestinal effects of diets low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols. Curr Opin Clin Nutr Metab Care 2022;25:260-4. [PMID: 35762162 DOI: 10.1097/MCO.0000000000000841] [Reference Citation Analysis]
18 Melchior C, Algera J, Colomier E, Törnblom H, Simrén M. Irritable bowel syndrome with food-related symptoms: Future directions in the clinical management. United European Gastroenterol J 2022. [PMID: 35727703 DOI: 10.1002/ueg2.12265] [Reference Citation Analysis]
19 Hungin APS, Scarpignato C, Keefer L, Corsetti M, Anastasiou F, Muris JWM, Mendive JM, Kahrilas PJ. Review article: rethinking the "ladder" approach to reflux-like symptom management in the era of PPI "resistance" - a multidisciplinary perspective. Aliment Pharmacol Ther 2022;55:1492-500. [PMID: 35460095 DOI: 10.1111/apt.16930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Melchior C, Algera J, Colomier E, Törnblom H, Simrén M, Störsrud S. Food Avoidance and Restriction in Irritable Bowel Syndrome: Relevance for Symptoms, Quality of Life and Nutrient Intake. Clin Gastroenterol Hepatol 2022;20:1290-1298.e4. [PMID: 34229035 DOI: 10.1016/j.cgh.2021.07.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 14.0] [Reference Citation Analysis]
21 Chey WD, Tack J. The Role of Food in Disorders of Gut-Brain Interaction: Introduction to a Rome Foundation Working Group Series. Am J Gastroenterol 2022;117:935-6. [PMID: 35333780 DOI: 10.14309/ajg.0000000000001744] [Reference Citation Analysis]
22 Murray HB, Doerfler B, Harer KN, Keefer L. Psychological Considerations in the Dietary Management of Patients With DGBI. Am J Gastroenterol 2022;117:985-94. [PMID: 35404301 DOI: 10.14309/ajg.0000000000001766] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
23 Scarlata K, Eswaran S, Baker JR, Chey WD. Utilization of Dietitians in the Management of Irritable Bowel Syndrome by Members of the American College of Gastroenterology. Am J Gastroenterol 2022;117:923-6. [PMID: 35014976 DOI: 10.14309/ajg.0000000000001602] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Sasegbon A, Hasan SS, Whorwell PJ, Vasant DH. Experience and clinical efficacy of gut‐directed hypnotherapy in an Asian population with refractory irritable bowel syndrome. JGH Open. [DOI: 10.1002/jgh3.12770] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Whelan K. Group education by dietitians in patients with gastrointestinal disorders: Potentially clinically effective and time for randomised trials. J Hum Nutr Diet 2022;35:417-20. [PMID: 35578390 DOI: 10.1111/jhn.13010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Ochoa KC, Samant S, Liu A, Duysburgh C, Marzorati M, Singh P, Hachuel D, Chey W, Wallach T. In-Vitro Efficacy of Targeted FODMAP Enzymatic Digestion (FODZYME®) in a High-Fidelity Simulated Gastrointestinal Environment.. [DOI: 10.1101/2022.05.16.492152] [Reference Citation Analysis]
27 Chen LJ, Kamp K, Fang A, Heitkemper MM. Delivery Methods of Cognitive Behavior Therapy for Patients With Irritable Bowel Syndrome. Gastroenterol Nurs 2022. [PMID: 35561102 DOI: 10.1097/SGA.0000000000000671] [Reference Citation Analysis]
28 Chey WD, Hashash JG, Manning L, Chang L. AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review. Gastroenterology 2022;162:1737-1745.e5. [PMID: 35337654 DOI: 10.1053/j.gastro.2021.12.248] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
29 Katherine Jurek M, Seavey H, Guidry M, Slomka E, Hunter SD. The effects of slow deep breathing on microvascular and autonomic function and symptoms in adults with irritable bowel syndrome: A pilot study. Neurogastroenterol Motil 2022;34:e14275. [PMID: 34595801 DOI: 10.1111/nmo.14275] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Gibson PR, Halmos EP, So D, Yao CK, Varney JE, Muir JG. Diet as a therapeutic tool in chronic gastrointestinal disorders: Lessons from the FODMAP journey. J Gastroenterol Hepatol 2022;37:644-52. [PMID: 34994019 DOI: 10.1111/jgh.15772] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
31 Staudacher HM, Rossi M, Kaminski T, Dimidi E, Ralph FSE, Wilson B, Martin LD, Louis P, Lomer MCE, Irving PM, Whelan K. Long-term personalized low FODMAP diet improves symptoms and maintains luminal Bifidobacteria abundance in irritable bowel syndrome. Neurogastroenterol Motil 2022;34:e14241. [PMID: 34431172 DOI: 10.1111/nmo.14241] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
32 Weber HC. Irritable bowel syndrome and diet. Curr Opin Endocrinol Diabetes Obes 2022;29:200-6. [PMID: 35131984 DOI: 10.1097/MED.0000000000000720] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Kassebaum-Ladewski A, Poppers DM, Brenner DM. Effective Communication Strategies and Tools for Improving Treatment Outcomes in Patients With Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation. Am J Gastroenterol 2022;117:S14-20. [PMID: 35354771 DOI: 10.14309/ajg.0000000000001686] [Reference Citation Analysis]
34 Noble H, Hasan SS, Whorwell PJ, Vasant DH. The symptom burden of Irritable Bowel Syndrome in tertiary care during the COVID-19 pandemic. Neurogastroenterol Motil 2022;34:e14347. [PMID: 35238428 DOI: 10.1111/nmo.14347] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
35 Keefer L, Ballou SK, Drossman DA, Ringstrom G, Elsenbruch S, Ljótsson B. A Rome Working Team Report on Brain-Gut Behavior Therapies for Disorders of Gut-Brain Interaction. Gastroenterology 2022;162:300-15. [PMID: 34529986 DOI: 10.1053/j.gastro.2021.09.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 17.0] [Reference Citation Analysis]
36 Whelan K. FODMAPs or gluten as inducers of symptoms in irritable bowel syndrome: separating the wheat from the chaff. Am J Clin Nutr 2021:nqab381. [PMID: 34910099 DOI: 10.1093/ajcn/nqab381] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Nordin E, Brunius C, Landberg R, Hellström PM. FODMAPs, but not gluten, elicit modest symptoms of irritable bowel syndrome: a double-blind, placebo-controlled, randomized three-way crossover trial. Am J Clin Nutr 2021:nqab337. [PMID: 34617561 DOI: 10.1093/ajcn/nqab337] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
38 Taft TH, Carlson DA, Simons M, Zavala S, Hirano I, Gonsalves N, Pandolfino JE. Esophageal Hypervigilance and Symptom-Specific Anxiety in Patients with Eosinophilic Esophagitis. Gastroenterology 2021;161:1133-44. [PMID: 34153298 DOI: 10.1053/j.gastro.2021.06.023] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
39 Chang L. How to Approach a Patient with Difficult-to-Treat IBS. Gastroenterology 2021;161:1092-1098.e3. [PMID: 34331916 DOI: 10.1053/j.gastro.2021.07.034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
40 Algera JP, Störsrud S, Lindström A, Simrén M, Törnblom H. Gluten and fructan intake and their associations with gastrointestinal symptoms in irritable bowel syndrome: A food diary study. Clin Nutr 2021;40:5365-72. [PMID: 34560607 DOI: 10.1016/j.clnu.2021.09.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
41 Jagielski CH, Riehl ME. Behavioral Strategies for Irritable Bowel Syndrome: Brain-Gut or Gut-Brain? Gastroenterol Clin North Am 2021;50:581-93. [PMID: 34304789 DOI: 10.1016/j.gtc.2021.03.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
42 Berry SK, Chey WD. Integrated Care for Irritable Bowel Syndrome: The Future Is Now. Gastroenterol Clin North Am 2021;50:713-20. [PMID: 34304796 DOI: 10.1016/j.gtc.2021.04.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Friesen C, Colombo JM, Deacy A, Schurman JV. An Update on the Assessment and Management of Pediatric Abdominal Pain. Pediatric Health Med Ther 2021;12:373-93. [PMID: 34393542 DOI: 10.2147/PHMT.S287719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
44 Goodoory VC, Mikocka-Walus A, Yiannakou Y, Houghton LA, Black CJ, Ford AC. Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome. Am J Gastroenterol 2021;116:1485-94. [PMID: 33840729 DOI: 10.14309/ajg.0000000000001247] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
45 Quigley EMM. Low FODMAP (fermentable oligo-, di-, monosaccharides, and polyol) diet goes global. Am J Clin Nutr 2021;113:1394-5. [PMID: 33851195 DOI: 10.1093/ajcn/nqab084] [Reference Citation Analysis]
46 Yang PL, Heitkemper MM, Kamp KJ. Irritable bowel syndrome in midlife women: a narrative review. Womens Midlife Health 2021;7:4. [PMID: 34059117 DOI: 10.1186/s40695-021-00064-5] [Reference Citation Analysis]
47 Tsukanov VV, Vasyutin AV, Tonkikh JL. Modern aspects of the management of patients with irritable bowel syndrome. Medicinskij sovet 2021. [DOI: 10.21518/2079-701x-2021-5-22-28] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Sasegbon A, Vasant DH. Understanding racial disparities in the care of patients with irritable bowel syndrome: The need for a unified approach. Neurogastroenterol Motil 2021;33:e14152. [PMID: 33835634 DOI: 10.1111/nmo.14152] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
49 Patel S, Doerfler B, Boutros K, Ng S, Manuel M, DeSimone E. Review of Treatment Options for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation. Int J Gen Med 2021;14:1457-68. [PMID: 33907450 DOI: 10.2147/IJGM.S274568] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
50 Riehl ME, Scarlata K. Understanding Disordered Eating Risks in Patients with Gastrointestinal Conditions. J Acad Nutr Diet 2021:S2212-2672(21)00172-6. [PMID: 33893063 DOI: 10.1016/j.jand.2021.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Heinrich H. Low-FODMAP-Diät – Lösung aller Probleme? Schweiz Gastroenterol 2021;2:24-29. [DOI: 10.1007/s43472-021-00035-1] [Reference Citation Analysis]
52 Wilmes L, Collins JM, O'Riordan KJ, O'Mahony SM, Cryan JF, Clarke G. Of bowels, brain and behavior: A role for the gut microbiota in psychiatric comorbidities in irritable bowel syndrome. Neurogastroenterol Motil 2021;33:e14095. [PMID: 33580895 DOI: 10.1111/nmo.14095] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
53 Perisetti A, Goyal H. Successful Distancing: Telemedicine in Gastroenterology and Hepatology During the COVID-19 Pandemic. Dig Dis Sci 2021;66:945-53. [PMID: 33655456 DOI: 10.1007/s10620-021-06874-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]